GI Oncology Now Conference Coverage
GI Oncology Now reviews education from ASCO GI 2024, featuring the latest advances in the field of GI cancer research.
Coverage of the 2024 ASCO GI Symposium, focusing on liver cancer
GI Oncology Now reviews education from ISGIO 2023, featuring the latest advances in the field of GI cancer research.
GI Oncology Now reviews practice-enhancing education from CIO 2023, featuring multidisciplinary specialties in oncology.
Advertisement
The Latest From GI Oncology Now
Matthew Strickland, MD, discusses the current management of defective mismatch repair in gastroesophageal adenocarcinoma.
Researchers conducted a comprehensive analysis to determine the association between HCC disease stage and prognosis.
RNA biomarkers are not reliant on age-related methylation patterns that may result in test performance variability.
The effects of primary tumor and LN volume on clinical outcomes in ESCC following neoadjuvant CCRT and surgery are unknown.
PRECEDE offers testing for individuals at high risk of pancreatic cancer, with multiple testing sites located globally.
Dr. Rodón Ahnert compares the differences of sacituzumab tirumotecan use in the second- vs third-line setting for patients.
Dr. Goel discusses how his team's liquid biopsy can be used with CA19-9 to boost the accuracy of detecting pancreatic cancer.
Colorectal cancer screening intervals can potentially be extended to 15 years to avoid unnecessary invasive examinations.
Advertisement
